← Back to Patent Explorer
US4288431A Expired / Lapsed US ⏱️ 0.0 years remaining

Cyclosporin derivatives, their production and pharmaceutical compositions containing them

Assignee: Novartis AG
•
Filing: 1979-10-12
•
Granted: 1981-09-08
•
Expires: 1999-10-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of formula I ##STR1## selected from the group consisting of cyclosporin G, wherein A is ##STR2## dihydrocyclosporin G, wherein A is ##STR3## and isocyclosporin G, wherein A is ##STR4## are useful in treating inflammations and arthritis and as immuno-suppressant agents.

Inventors

  • 👤 Rene P. Traber
  • 👤 Hans Hofmann
  • 👤 Eugen Harri
  • 👤 Kuhn Max

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 16:54
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/64; C07K7/645; C12; C12N; C12N1/00; C12N1/14; C12N1/145; A; A61; A61K; A61K38/00; C12R; C12R2001/00; C12R2001/645; C12R2001/885; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/19; Y10S930/27

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 31 words
A compound of formula I ##STR6## selected from the group consisting of cyclosporin G, wherein A is ##STR7## dihydrocyclosporin G, wherein A is ##STR8## and isocyclosporin G, wherein A is ##STR9##
Claim 2
Dependent Claim 31 words
A compound of formula I ##STR6## selected from the group consisting of cyclosporin G, wherein A is ##STR7## dihydrocyclosporin G, wherein A is ##STR8## and isocyclosporin G, wherein A is ##STR9##
Claim 3
Dependent Claim 83 words
The compound of claim 1 which is cyclosporin G which has the following approximate characteristics: ##EQU3## UV spectrum in CH 3 OH: end absorption IR spectrum in CH 2 Cl 2 : see FIG. 1 IH.N.M.R. spectrum in CDCl 3 90 MH z (Tetramethylsilane as internal standard): see FIG. 2 Formula: C 63 H 113 N 11 O 12 and when in crystalline form a m.pt. of about 193°-194° C., and being more polar than cyclosporin D and less polar than cyclosporin A.
Claim 4
Dependent Claim 14 words
The compound of claim 1 which is cyclosporin G substantially free from cyclosporin D.
Claim 5
Dependent Claim 14 words
The compound of claim 1 which is cyclosporin G in greater than 95% purity.
Claim 6
Dependent Claim 89 words
The compound of claim 1 which is dihydrocyclosporin G having the following approximate characteristics: [α] D 20 =-232° (c=0.64 in CHCl 3 ) UV spectrum in CH 3 OH: end absorption IR spectrum in CH 2 Cl 2 : see FIG. 3 IH.N.M.R. spectrum in CDCl 3 , 90 MH z (Tetramethylsilane as internal standard): see FIG. 4 Formula: C 63 H 115 N 11 O 12 and when in amorphous powder form a m.pt. of 150°-153° C. and obtainable by hydrogenating cyclosporin G as defined in claim 1.
Claim 7
Dependent Claim 9 words
The compound of claim 1 which is isocyclosporin G.
Claim 8
Dependent Claim 72 words
A process for the production of a compound of claim 1 which comprises, (a) cultivating a cyclosporin G-producing strain of the fungal species Tolypocladium under aerobic conditions in the presence of a nutrient medium until a sufficient amount of cyclosporin G is produced and thereafter isolating cyclosporin G, or (b) reducing cyclosporin G by catalytic hydrogenation to produce dihydrocyclosporin G, or (c) rearranging cyclosporin G under acidic conditions to produce isocyclosporin G.
Claim 9
Dependent Claim 30 words
A pharmaceutical composition useful in treating chronic inflammations or immunosuppressant disorders comprising a therapeutically effective amount of a compound of claim 1 in association with a pharmaceutical carrier or diluent.
Claim 10
Dependent Claim 32 words
A method of treating chronic inflammations or immunosuppressant disorders in animals, which comprises administering a therapeutically effective amount of a compound of claim 1 to an animal in need of said treatment.

References Cited (Backward Citations)

US4108985A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-09-07 1985-03-09 1985-09-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-09-07 1989-03-09 1989-09-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-09-07 1993-03-09 1993-09-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag